Article information
The nose and lungs have both histological and functional similarities and differences. Sinonasal and bronchial involvement are associated in many diseases. Cystic fibrosis, primary ciliary dyskinesia, Young's syndrome, and α-1 antitrypsin deficiency are diseases in which bronchiectasis and rhinosinusitis are both present. This review considers the diseases in which bronchiectasis occurs along with sinonasal manifestations. We propose examining sinonasal disease from a new perspective by observing it in patients with bronchiectasis.
Key words:
Rhinitis
Sinusitis
Bronchiectasis
La nariz y el bronquio presentan similitudes y diferencias tanto histológicas como funcionales. Son muchas las enfermedades en que se asocian la afección nasosinusal y la bronquial. La fibrosis quística, la discinesia ciliar primaria, el síndrome de Young y el déficit de alfa-1-antitripsina son enfermedades en las que se asocian bronquiectasias y rinosinusitis. En este artículo se realiza una revisión de las bronquiectasias y de las enfermedades que las asocian junto a afección nasosinusal. El propósito es dar un nuevo enfoque de la patología nasosinusal observada en los pacientes afectados de bronquiectasias.
Palabras clave:
Rinitis
Sinusitis
Bronquiectasias
Full text is only aviable in PDF
REFERENCES
[1]
FE Simons.
Allergic rhinobronchitis: the asthma-allergic rhinitis link.
J Allergy Clin Immunol, 104 (1999), pp. 534-540
[2]
C Bachert, AM Vignola, P Gevaert, B Leynaert, P van Cauwenberge, J Bousquet.
Allergic rhinitis, rhinosinusitis, and asthma: one airway disease.
Immunol Allergy Clin Am, 24 (2004), pp. 19-43
[3]
J Bousquet, P van Cauwenberge, N Khaltaev, World Health Organization.
Allergic rhinitis and its impact on asthma.
J Allergy Clin Immunol, 108 (2001), pp. S147-S334
[4]
DF Proctor.
The upper airways. Nasal physiology and defense of the lungs.
Am Rev Respir Dis, 115 (1977), pp. 97-119
[5]
K Zhao, PW Scherer, SA Hajiloo, P Dalton.
Effect of anatomy on human nasal air flow and odorant transport patterns: implications for olfaction.
Chem Senses, 29 (2004), pp. 365-379
[6]
M Gaga, AM Vignola, P Chánez.
Upper and lower airways: similarities and differences.
WallaërtBChánezPGodardP. The nose and lung diseases, 18 (2001), pp. 10-15
[7]
WR Roche, R Beasley, JH Williams, ST Holgate.
Subepithelial fibrosis in the bronchi of asthmatics.
Lancet, 11;1 (1989), pp. 520-524
[8]
A Martínez-Hernandez, PS Amenta.
The basement membrane in pathology.
Lab Invest, 48 (1983), pp. 656-677
[9]
P Chánez, AM Vignola, P Vic, F Guddo, G Bonsignore, P Godard, et al.
Comparison between nasal and bronchial inflammation in asthmatic and control subjects.
Am J Respir Crit Care Med, 159 (1999), pp. 588-595
[10]
J Rutland, WM Griffin, PJ Cole.
Human ciliary beat frequency in epithelium from intrathoracic and extrathoracic airways.
Am Rev Respir Dis, 125 (1982), pp. 100-105
[11]
CA Owen, EJ Campbell, SL Hill, RA Stockley.
Increased adherence of monocytes to fibronectin in bronchiectasis.
Am Rev Respir Dis, 146 (1992), pp. 626-631
[12]
B Leynaert, F Neukirch, P Demoly, J Bousquet.
Epidemiologic evidence for asthma and rhinitis comorbidity.
J Allergy Clin Immunol, 106 (2000), pp. 201-205
[13]
GA Settipane, FH Chafee.
Nasal polyps in asthma and rhinitis. A review of 6037 patients.
J Allergy Clin Immunol, 59 (1977), pp. 17-21
[14]
S Hurd.
The impact of COPD on lung health worldwide: epidemiology and incidence.
Chest, 117 (2000), pp. 1S-4S
[15]
I Vachier, AM Vignola, G Chiappara, A Bruno, H Meziane, P Godard, et al.
Inflammatory features of nasal mucosa in smokers with and without COPD.
Thorax, 59 (2004), pp. 303-307
[16]
NJ Roberts, SJ Lloyd-Owen, F Rapado, IS Patel, TM Wilkinson, GC Donaldson, et al.
Relationship between chronic nasal and respiratory symptoms in patients with COPD.
Respir Med, 97 (2003), pp. 909-914
[17]
J Angrill, C Agustí, A Torres.
Bronchiectasis.
Curr Opin Infect Dis, 14 (2001), pp. 193-197
[18]
RTH Laennec.
A treatise on the disease of the chest, pp. 78
[19]
LM Reid.
Reduction in bronchial subdivision in bronchiectasis.
Thorax, 5 (1950), pp. 233-247
[20]
PJ Cole.
Inflammation: a two-edged sword -the model of bronchiectasis.
Eur J Respir Dis Suppl, 147 (1986), pp. 6-15
[21]
M Gaga, AM Bentley, M Humbert, J Barkans, F O'Brien, CG Wathen, et al.
Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis.
Thorax, 53 (1998), pp. 685-691
[22]
AH Limper, UB Prakash.
Tracheobronchial foreign bodies in adults.
Ann Intern Med, 15 (1990), pp. 604-609
[23]
KW Tsang, K Chan, P Ho, L Zheng, GC Ooi, JC Ho, et al.
Sputum elastase in steady-state bronchiectasis.
Chest, 117 (2000), pp. 420-426
[24]
JB Richman-Eisenstat, PG Jorens, CA Hebert, I Ueki, JA Nadel.
Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.
Am J Physiol, 264 (1993), pp. L413-L418
[25]
DK Shum, SC Chan, MS Ip.
Neutrophil-mediated degradation of lung proteoglycans: stimulation by tumor necrosis factor-alpha in sputum of patients with bronchiectasis.
Am J Respir Crit Care Med, 162 (2000), pp. 1925-1931
[26]
J Tamaoki, A Chiyotani, K Kobayashi, N Sakai, T Kanemura, T Takizawa.
Effect of indomethacin on bronchorrhea in patients with chronic bronchitis, diffuse panbronchiolitis, or bronchiectasis.
Am Rev Respir Dis, 145 (1992), pp. 548-552
[27]
J Angrill, C Agustí, R de Celis, A Rano, J González, T Solé, et al.
Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors.
Thorax, 57 (2002), pp. 15-19
[28]
MB Nicotra, M Rivera, AM Dale, R Shepherd, R Carter.
Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort.
Chest, 108 (1995), pp. 955-961
[29]
AF Barker.
Bronchiectasis.
N Engl J Med, 346 (2002), pp. 1383-1393
[31]
IS Patel, I Vlahos, TM Wilkinson, SJ Lloyd-Owen, GC Donaldson, M Wilks, et al.
Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 170 (2004), pp. 400-407
[32]
T Keistinen, O Saynajakangas, T Tuuponen, SL Kivela.
Bronchiectasis: an orphan disease with a poorly understood prognosis.
Eur Respir J, 10 (1997), pp. 2784-2787
[33]
JM Rommens, MC Iannuzzi, B Kerem, ML Drumm, G Melmer, M Dean, et al.
Identification of the cystic fibrosis gene: chromosome walking and jumping.
Science, 245 (1989), pp. 1059-1065
[34]
FS Collins.
Cystic fibrosis: molecular biology and therapeutic implications.
Science, 256 (1992), pp. 774-779
[35]
M Gilljam, L Ellis, M Corey, J Zielenski, P Durie, DE Tullis.
Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood.
Chest, 126 (2004), pp. 1215-1224
[36]
B Wood.
Cystic fibrosis: 1997.
Radiology, 204 (1977), pp. 1-10
[37]
MW Yung, J Gould, GJ Upton.
Nasal polyposis in children with cystic fibrosis: a long-term follow-up study.
Ann Otol Rhinol Laryngol, 111 (2002), pp. 1081-1086
[38]
L Wang, SD Freedman.
Laboratory tests for the diagnosis of cystic fibrosis.
Am J Clin Pathol, 117 (2002), pp. 109-115
[39]
A Salcedo, RM Girón, B Beltrán, A Martínez, L Máiz, L Suárez, Fundación Sira Carrasco.
Conferencia de consenso. Tratamiento antibiótico intravenoso domiciliario en la fibrosis quística; 2002, abril 26.
Arch Bronconeumol, 39 (2003), pp. 469-475
[41]
ME Coren, M Meeks, I Morrison, RM Buchdahl, A Bush.
Primary ciliary dyskinesia: age at diagnosis and symptom history.
Acta Paediatr, 91 (2002), pp. 667-669
[42]
GY Chin, DE Karas, M Kashgarian.
Correlation of presentation and pathologic condition in primary ciliary dyskinesia.
Arch Otolaryngol Head Neck Surg, 128 (2002), pp. 1292-1294
[43]
M Armengot, C Carda, A Escribano, GJ Samper.
Estudio del transporte mucociliar y de la ultraestructura ciliar nasales en pacientes con síndrome de Kartagener.
Arch Bronconeumol, 41 (2005), pp. 11-15
[44]
PG Noone, MW Leigh, A Sannuti, SL Minnix, JL Carson, M Hazucha, et al.
Primary ciliary dyskinesia: diagnostic and phenotypic features.
Am J Respir Crit Care Med, 169 (2004), pp. 459-467
[45]
R Corbelli, B Bringolf-Isler, A Amacher, B Sasse, M Spycher, J Hammer.
Nasal nitric oxide measurements to screen children for primary ciliary dyskinesia.
Chest, 126 (2004), pp. 1054-1059
[46]
C Domingo, RM Mirapeix, B Encabo, J Roig, D López, J Ruiz.
Hallazgos clínicos y ultraestructura de la discinesia ciliar primaria y el síndrome de Young.
Rev Clin Esp, 197 (1997), pp. 100-103
[47]
DJ Handelsman, AJ Conway, LM Boylan, JR Turtle.
Young's syndrome: Obstructive azoospermia and chronic sinopulmonary infections.
N Engl J Med, 310 (1984), pp. 3-9
[48]
JF Tomashefski Jr, RG Crystal, HP Wiedemann, E Mascha, JK Stoller, Alpha 1-Antitrypsin Deficiency Registry Study Group.
The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with Severe Deficiency of Alpha-1 Antitrypsin.
Hum Pathol, 35 (2004), pp. 1452-1461
[49]
DC Hutchison, D Cooper, British Thoracic Society.
Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials.
Respir Med, 96 (2002), pp. 872-880
[50]
DA Lomas, H Parfrey.
Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.
Thorax, 59 (2004), pp. 529-535
[51]
C de la Roza, X Costa, R Vidal, S Vila, F Rodríguez-Frías, R Jardí, et al.
Programa de cribado para el déficit α1–antitripsina en pacientes con EPOC mediante el uso de gota de sangre en papel secante.
Arch Bronconeumol, 39 (2003), pp. 8-12
[52]
C Strange, R Dickson, C Carter, MJ Carpenter, B Holladay, R Lundquist, et al.
Genetic testing for alpha1–antitrypsin deficiency.
Genet Med, 6 (2004), pp. 204-210
[53]
American Thoracic Society/European Respiratory Society Statement.
Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.
Am J Respir Crit Care Med, 168 (2003), pp. 818-900
Copyright © 2006. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
